Literature DB >> 10191218

Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients.

V G Fowler1, L K Kong, G R Corey, G S Gottlieb, R S McClelland, D J Sexton, D Gesty-Palmer, L J Harrell.   

Abstract

To identify risk factors for relapse among 309 prospectively identified cases of Staphylococcus aureus bacteremia, patients with recurrent S. aureus bacteremia were identified, and pulsed-field gel electrophoresis (PFGE) was performed on isolates from both episodes. PFGE banding patterns from both isolates were identical in 23 patients, consistent with relapsed infection. Patients with PFGE-confirmed relapse were more likely by both univariate and multivariate analyses to have an indwelling foreign body (odds ratio [OR]=18.2, 95% confidence interval [CI]=7. 6-43.6; P<.001), to have received vancomycin therapy (OR=4.1, 95% CI=1.5-11.6; P=.008), or be hemodialysis-dependent (OR=4.1, 95% CI=1. 8-9.3; P=.002) than patients who did not develop recurrent bacteremia. These results suggest that recurrent episodes of S. aureus bacteremia are primarily relapses and are associated with an indwelling foreign body, receiving vancomycin therapy, and hemodialysis dependence.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191218     DOI: 10.1086/314712

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients.

Authors:  David J Rodriguez; Aisha Afzal; Rudolph Evonich; David E Haines
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Authors:  Sung-Han Kim; Kye-Hyung Kim; Hong-Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2007-11-05       Impact factor: 5.191

3.  Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.

Authors:  Thomas P Lodise; Peggy S McKinnon; Donald P Levine; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

4.  Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.

Authors:  J John Weems; James P Steinberg; Scott Filler; John W Baddley; G Ralph Corey; Priya Sampathkumar; Lisa Winston; Joseph F John; Christine J Kubin; Rohit Talwani; Thomas Moore; Joseph M Patti; Seth Hetherington; Michele Texter; Eric Wenzel; Violet A Kelley; Vance G Fowler
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

5.  Improving Clinical Outcomes in Patients With Methicillin-Sensitive Staphylococcus aureus Bacteremia and Reported Penicillin Allergy.

Authors:  Kimberly G Blumenthal; Robert A Parker; Erica S Shenoy; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2015-05-19       Impact factor: 9.079

6.  Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia.

Authors:  M L H Cuijpers; F J Vos; C P Bleeker-Rovers; P F M Krabbe; P Pickkers; A P J van Dijk; G J A Wanten; P D Sturm; W J G Oyen; B J Kullberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

7.  Predictors of relapse of methicillin-resistant Staphylococcus aureus bacteremia after treatment with vancomycin.

Authors:  Kerry J Welsh; Kimberly A Skrobarcek; April N Abbott; Cole T Lewis; Mark C Kruzel; Evan M Lewis; Jeanelle M Gardiner; John F Mohr; Lisa Y Armitige; Audrey Wanger
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

8.  Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Authors:  Kevin E Chan; H Shaw Warren; Ravi I Thadhani; David J R Steele; Jeffrey L Hymes; Franklin W Maddux; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2012-08-16       Impact factor: 10.121

9.  Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.

Authors:  Alexa A Pragman; Michael A Kuskowski; James M Abraham; Gregory A Filice
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2012-07-01

10.  Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model.

Authors:  Yan Q Xiong; Vance G Fowler; Michael R Yeaman; Francoise Perdreau-Remington; Barry N Kreiswirth; Arnold S Bayer
Journal:  J Infect Dis       Date:  2009-01-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.